李清瑜, 高晶晶, 付延津, 龙孟莎, 章依垚, 蒙祖玉, 林少姿, 秦佳佳*. 左归丸联合西曲瑞克调节卵巢储备功能作用研究J. 药学学报, 2022,57(7): 2108-2114. doi: 10.16438/j.0513-4870.2022-0187
引用本文: 李清瑜, 高晶晶, 付延津, 龙孟莎, 章依垚, 蒙祖玉, 林少姿, 秦佳佳*. 左归丸联合西曲瑞克调节卵巢储备功能作用研究J. 药学学报, 2022,57(7): 2108-2114. doi: 10.16438/j.0513-4870.2022-0187
LI Qing-yu, GAO Jing-jing, FU Yan-jin, LONG Meng-sha, ZHANG Yi-yao, MENG Zu-yu, LIN Shao-zi, QIN Jia-jia*. The regulation of ovarian reserve function by Zuogui pills combined with cetrorelixJ. Acta Pharmaceutica Sinica, 2022,57(7): 2108-2114. doi: 10.16438/j.0513-4870.2022-0187
Citation: LI Qing-yu, GAO Jing-jing, FU Yan-jin, LONG Meng-sha, ZHANG Yi-yao, MENG Zu-yu, LIN Shao-zi, QIN Jia-jia*. The regulation of ovarian reserve function by Zuogui pills combined with cetrorelixJ. Acta Pharmaceutica Sinica, 2022,57(7): 2108-2114. doi: 10.16438/j.0513-4870.2022-0187

左归丸联合西曲瑞克调节卵巢储备功能作用研究

The regulation of ovarian reserve function by Zuogui pills combined with cetrorelix

  • 摘要: 探讨补肾养阴方药左归丸联合促性腺激素释放激素拮抗剂西曲瑞克调节SIRT1/P53/P21对卵巢储备功能下降(decreasing ovarian reserve,DOR)小鼠卵巢局部氧化应激反应的影响。所有动物实验均在暨南大学实验动物管理委员会的指导和标准下进行。以环磷酰胺(cyclophosphamide,CTX)诱导的DOR小鼠为实验对象,分别灌胃给予左归丸、西曲瑞克及两药联合治疗。治疗结束后,观察小鼠动情周期变化、血清性激素水平、氧化应激相关指标、生长生化因子水平及SIRT1/P53/P21的表达情况。结果显示,与模型组比较,左归丸和联合用药组可明显延长动情期、缩短动情间期,联合用药组更可明显缩短周期长度;与模型组比较,各治疗组性激素相关指标检测均出现卵泡刺激素(follicle-stimulating hormone,FSH)下降、雌二醇(estradiol,E2)增高,氧化应激指标一氧化氮合酶(nitric oxide synthase,NOS)、一氧化氮(nitric oxide,NO)及活性氧(reactive oxygen species,ROS)下降,生长生化因子指标脑源性神经营养因子(brain derived neurotrophic factor,BDNF)及生长分化因子9(growth differentiaction factor 9,GDF-9)浓度均明显上升,白血病抑制因子(leukemia inhibitory factor,LIF)在各治疗组与模型组差异不显著;SIRT1/P53/P21免疫组化结果显示,与模型组相比,各治疗组SIRT1表达增加,P53和P21蛋白表达减少,其中联合用药组各项指标差异显著,效果最优。综上所述,西曲瑞克联合补肾养阴方药左归丸可通过调控SIRT1/P53/P21通路改善卵泡内的氧化应激反应,减少过氧化产物的产生,保护卵巢功能,从而调节卵巢激素的分泌,其疗效优于单用西曲瑞克或左归丸。

     

    Abstract: The purpose of this study was to investigate how Zuogui pills from the Kidney-tonifying and Nourishing Yin formula, in combination with the gonadotrophin-releasing hormone antagonist cetrorelix, affected the ovarian local oxidative stress response in decreasing ovarian reserve (DOR) mice. All animal experiments were carried out in accordance with the guidelines and standards established by Jinan University's Experimental Animal Management Committee. Cyclophosphamide (CTX)-treated DOR mice were given Zuogui pills, cetrorelix, or a combination of the two drugs intragastrically. After treatment, there were changes in the estrous cycle, serum sex hormone levels, oxidative stress-related indexes, growth biochemical factor levels, and SIRT1/P53/P21 expression. In comparison to the model group, the Zuogui pills and the cetrorelix+Zuogui pills group had significantly prolonged estrous periods and shortened interestrous periods, and the cetrorelix+Zuogui pills group had a significantly shortened cycle length. Follicle-stimulating hormone (FSH) decreased and estradiol (E2) increased in all treatment groups compared to the model group, oxidative stress indexes nitric oxide synthase (NOS), nitric oxide (NO), and reactive oxygen species (ROS) decreased, growth biochemical factors brain derived neurotrophic factor (BDNF) and growth differentiation factor 9 (GDF-9) concentrations increased significantly, and leukemia inhibitory factor (LIF) showed no significant change. SIRT1/P53/P21 immunohistochemical results revealed that, when compared to the model group, the expression of SIRT1 increased while the expression of P53 and P21 proteins decreased in all treatment groups, with the cetrorelix+Zuogui pills group having the largest decrease, with significant differences in all indicators. We conclude that cetrorelix combined with Zuogui pills for kidney nourishing and Yin recipe improved the oxidative stress response in the follicle by regulating the SIRT1/P53/P21 pathway, reducing peroxide product production, protecting ovarian function, and regulating ovarian hormone secretion, and its efficacy is superior to that of cetrorelix or Zuogui pills alone.

     

/

返回文章
返回